GlassScriptPhysician profile
Gregory J Chapis
NPI 1134192610
$4,504.12
in general payments reported to CMS, 2019-2025
52 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $185 · 2021: $562 · 2022: $353 · 2023: $546 · 2024: $539 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $550.05 | 2024-2025 | Qutenza |
| Amgen INC. | $317.32 | 2019-2025 | Evenity, Prolia, Prolia |
| Boston Scientific Corporation | $309.96 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Biodelivery Sciences International, INC. | $284.78 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $281.03 | 2021-2024 | Ztlido |
| Abbvie INC. | $226.73 | 2021-2025 | Qulipta, Botox |
| Mallinckrodt Enterprises LLC | $221.89 | 2019 | |
| Vertos Medical, INC. | $160.56 | 2021-2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $156.55 | 2019-2025 | Prialt |
| Collegium Pharmaceutical, INC. | $153.36 | 2022-2025 | Xtampza |
| Si-Bone, INC. | $149.56 | 2021 | |
| Lundbeck LLC | $136.30 | 2024-2025 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.09 | 2019-2025 | Relistor |
| Ferring Pharmaceuticals INC. | $110.92 | 2024-2025 | Euflexxa |
| Valinor Pharma, LLC | $87.25 | 2024-2025 | Movantik |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Chapis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.